Soluble thrombomodulin as a predictor of type 2 diabetes: Results from the MONICA/KORA Augsburg case-cohort study, 1984-1998

Diabetologia

Volumn 50, Issue 3, 2007, Pages 545-548

  Thorand, B ^a   Baumert, J ^a   Herder, C ^b   Meisinger, C ^a   Koenig, W ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Case cohort study; Endothelial dysfunction; Incident type 2 diabetes; Soluble thrombomodulin

Indexed keywords

INSULIN; THROMBOMODULIN;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; GERMANY; HEART RATE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; THROMBOMODULIN;

EID: 33846829130     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0568-x     Document Type: Article

References (11)

1. Sadler JE (1997) Thrombomodulin structure and function. Thromb Haemost 78:392-395
2. Uehara S, Gotoh K, Handa H (2001) Separation and characterization of the molecular species of thrombomodulin in the plasma of diabetic patients. Thromb Res 104:325-332
3. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241-1248
4. Pinkney JH, Stehouwer CDA, Coppack SW, Yudkin JS (1997) Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 46(Suppl. 2):S9-S13
5. Aso Y, Inukai T, Takemura Y (1998) Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury. Metabolism 47:362-365
6. Salomaa V, Matei C, Aleksic N et al (1999) Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) study: a case-cohort study. Lancet 353:1729-1734
7. Tooke JE, Goh KL (1998) Endotheliopathy precedes type 2 diabetes. Diabetes Care 21:2047-2049
8. Thorand B, Baumert J, Chambless L, for the MONICA/KORA Study Group et al (2006) Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 26:398-405
9. Thorand B, Baumert J, Döring A et al (2006) Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study. Thromb Haemost 95:134-141
10. Olivot JM, Labreuche J, Aiach M, Amarenco P (2004) Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke 35:1946-1951
11. Levey AS, Coresh J, Balk E, National Kidney Foundation et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147